Morgan Stanley’s Biocept, Inc. BIOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Hold |
0
| – | – | – | 8018 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 8032 |
|
|
2022
Q2 | – | Sell |
-63
| Closed | -$4K | – | 8131 |
|
|
2022
Q1 | $4K | Buy |
63
+2
| +3% | +$127 | ﹤0.01% | 7662 |
|
|
2021
Q4 | $6K | Sell |
61
-235
| -79% | -$23.1K | ﹤0.01% | 7617 |
|
|
2021
Q3 | $35K | Sell |
296
-5,635
| -95% | -$666K | ﹤0.01% | 6878 |
|
|
2021
Q2 | $745K | Buy |
5,931
+5,928
| +197,600% | +$745K | ﹤0.01% | 5253 |
|
|
2021
Q1 | $1K | Sell |
3
-1,612
| -100% | -$537K | ﹤0.01% | 7415 |
|
|
2020
Q4 | $215K | Buy |
1,615
+1,612
| +53,733% | +$215K | ﹤0.01% | 5553 |
|
|
2020
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 6880 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6811 |
|
|
2019
Q1 | – | Sell |
-13
| Closed | -$3K | – | 6768 |
|
|
2018
Q4 | $3K | Buy |
+13
| New | +$3K | ﹤0.01% | 6387 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6860 |
|
|
2017
Q4 | – | Sell |
-1
| Closed | -$12K | – | 6699 |
|
|
2017
Q3 | $12K | Hold |
1
| – | – | ﹤0.01% | 6138 |
|
|
2017
Q2 | $14K | Hold |
1
| – | – | ﹤0.01% | 6170 |
|
|
2017
Q1 | $22K | Buy |
+1
| New | +$22K | ﹤0.01% | 6064 |
|
|
2016
Q4 | – | Hold |
0
| – | -$1K | – | 6590 |
|
|
2016
Q3 | – | Hold |
0
| – | -$3K | – | 6453 |
|
|
2016
Q2 | – | Hold |
0
| – | -$7K | – | 6322 |
|
|
2016
Q1 | – | Hold |
0
| – | -$15K | – | 6222 |
|
|
2015
Q4 | – | Sell |
-2
| Closed | -$152K | – | 6129 |
|
|
2015
Q3 | $152K | Hold |
2
| – | – | ﹤0.01% | 5225 |
|
|
2015
Q2 | $109K | Buy |
+2
| New | +$109K | ﹤0.01% | 5541 |
|
|
2015
Q1 | – | Hold |
0
| – | -$2K | – | 5981 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 6448 |
|
|
2014
Q3 | – | Hold |
0
| – | -$2K | – | 6695 |
|
|
2014
Q2 | – | Hold |
0
| – | -$2K | – | 6399 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 6356 |
|